Solid Tumor Research

Through discovery, innovation and collaboration, researchers at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta are searching for ways to improve the outcomes and quality of life for children with solid tumors.

Clinical and Translational Research

  • Targeted therapeutics
  • Novel drug combinations
  • Chemoresistance mechanisms
    • Aberrant apoptosis signaling
    • Tyrosine kinase regulation
  • High risk neuroblastoma therapy and outcomes

Clinical and Translational Researchers

Basic Research

  • Improving the effectiveness of chemotherapy in treating neuroblastoma by targeting molecular bodyguards that protect neuroblastoma cells. Learn more
  • Biologic validation of Phase I agents

Basic Researcher

    Research Collaborations

    The Aflac Cancer Center Solid Tumor team conducts leading-edge pediatric cancer research in conjunction with the following local, regional and national organizations: